Hey Investor, Welcome to Weekly Picks, where each week our analysts handpick their favorite Narratives. Narratives are a game-changing way for investors to make smarter decisions on their stocks. A narrative always has 3 parts: a story, a forecast and a fair value. You can create one yourself in 3 minutes or you can select one from our thriving community. This week’s picks cover: |
|
|
The "Molecular Pencil": Why Beam's Technology is Built to Win |
Beam Therapeutics’ base editing platform offers a safer, more precise alternative to CRISPR by rewriting single DNA letters without cutting the genome, validated by strong early data from its BEAM-302 trial. With robust financing, de-risked clinical assets, and unpriced upside from its ESCAPE platform, Beam is well-positioned to lead the next generation of genetic medicine. |
|
|
~63% undervalued vs current price |
Based on ~100% p.a. revenue growth for 5 years | | |
|
💡 Why we like it: It reads like a masterclass in scientific storytelling, translating complex molecular biology into a clear, conviction-driven investment case. It balances technical depth with a well-reasoned risk-adjusted valuation, turning Beam’s “molecular pencil” into both a metaphor and a compelling symbol of next-gen precision medicine. |
| |
| Taiwan Semiconductor Manufacturing |
|
|
The silent giant behind virtually every advanced chip powering AI, smartphones, and modern infrastructure |
TSMC’s accelerating AI and HPC demand continues to drive record growth and margin strength, prompting an upgrade to full-year revenue guidance amid robust global chip momentum. However, elevated valuations and rising cost pressures from overseas fab expansion and geopolitical risk narrow the margin of safety, making continued execution critical to sustain upside. |
|
|
Fairly valued vs current price |
Based on ~67% p.a. revenue growth for 3 years |
| |
|
💡 Why we like it: User oscargarcia has been diligently maintaining their narrative, delivering an update that tracks recent bullish momentum with measured caution, celebrating TSMC’s record-setting AI boom while openly weighing valuation and geopolitical headwinds. It’s a sharp, balanced read that turns complex financials into a clear, grounded investment narrative. |
|
|
| Automatic Data Processing |
|
|
Solid Fundamentals, But AI Investments Test Its Margin Resilience |
ADP’s transition from legacy payroll processing to AI-driven analytics aims to defend margins and sustain profitability in a maturing market rather than drive rapid growth. While its scale and cash flow resilience support long-term value, elevated investment in AI infrastructure may compress margins near term, making execution key to realizing its undervaluation potential. |
|
|
~34% undervalued vs current price |
Based on ~14% p.a. revenue growth for 10 years | | |
|
💡 Why we like it: It’s a refreshingly grounded view of ADP’s AI ambitions, framing innovation not as hype but as a disciplined defense of profitability. It’s a thoughtful, well-balanced narrative that blends valuation insight with strategic realism about transformation in a mature business. |
|
|
What's next?
1. 🔔 Know when to act: Set the narrative valuations as your own fair value to know when to buy, hold or sell the stock.
2. 🤔 Get answers: Ask the author any questions in the comments section. Feel free to like as well to support their work.
3. ✨ Discover more Narratives: There are hundreds of other insightful stock narratives on our Community page.
4. ✍️ Build an audience: Have your narrative seen by millions of investors, simply meet our Featuring criteria to go into the running! |
|
|
| This email is from Simply Wall Street Pty Ltd
Level 5, 320 Pitt St Sydney 2000, NSW, Australia. Simply Wall St has no position in the company(s) mentioned. These narratives are general in nature and explore scenarios and estimates created by the authors. These narratives do not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company’s future performance and are exploratory in the ideas they cover. The fair value estimates are for informational purposes only and do not constitute a recommendation to buy or sell any stock. They do not take into account your objectives or financial situation. Note that the author’s analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this email/website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us. Privacy Policy Terms and Conditions
Don’t want to get Weekly Pick emails? Click here to stop receiving it.
Want to stop receiving emails or want to check which email you are subscribed on? Click here to manage your email subscriptions. | | |
|
|
|
